A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02087007
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Registry
-
NCT02087007
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02087007. Randomized; double masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2015-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina
- Acronym
- STELLA
- Condition
- Vasospastic Angina
- Intervention (Drug)
- Cilostazol
- Intervention (Drug)
- placebo
- Lead sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct02087007- Content hash
a63437e0ab64a74fab64c27e33f925d968662ead4831852fe501cc496a05eef7